ILSI North America is committed to sharing the results of the research we support, regardless of the outcomes. Our publications undergo stringent peer-review by qualified experts prior to publication and include disclosure of all sources of funding.
This study highlights the potential utility of the RISK21 approach for interpretation of the ToxCast HTS data, as well as the challenges involved in integrating in vitro HTS data into safety assessments. This work was supported by the ILSI North America Food and Chemical Safety Committee 2016 Summer Fellowship.
The primary aim of this work was to evaluate a hypothesis on whether a foundational framework (decision tree) previously developed by the North American Branch of the International Life Sciences Institute (ILSI North America) Food and Chemical Safety Committee for a risk-based approach to mitigation of process-formed compounds could be applied to other not-readily-avoidable substances, such as mycotoxins.
A definition for “personalized nutrition” (PN) is proposed, along with 10 guiding principles that are intended to establish a basis for responsible approaches to the evidence-based research and practice of PN and serve as an invitation for further public dialog.
The authors of this study examined, for the first time, if there is consistent evidence that higher flavan-3-ol intake, irrespective of dietary source, reduces cardiometabolic risk.
ILSI North America previously took on the task of defining a “healthy gut microbiome,” and the outcome of this effort was published by Backhed et al. in 2012. Since that time, the body of work on gut microbiome has grown exponentially. In 2018, >40 invited academic, government, and industry experts gathered to evaluate progress toward this definition and explore the question: Can a Healthy Gut Microbiome be Defined Through Quantifiable Characteristics?